FORDYCE MARSHALL (President and CEO) sold 6.2% of their position (16.93K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $710.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2026ACC: 0001859453-26-000004
DirectorOfficer· President and CEO
Since May 2021
-16.93K
Net shares
Net seller
$710.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.93K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−16.93K
Price / share
$41.98
Trade value
$710.58K
% of position
6.2%
2/23/2026
274.09K→257.16K
Total
Net shares
−16.93K
Net value
-$710.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/23/2026 | S · Sale | −16.93K | $41.98 | $710.58K | 6.2% | 274.09K | 257.16K |
| Total | −16.93K | -$710.58K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Class A Common Stock
IndirectShares owned99.08K
Class A Common Stock
IndirectShares owned122.95K
Total
222.03K indirect222.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 99.08K | Indirect |
| Class A Common Stock | 122.95K | Indirect |
| Total | 222.03K | 222.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported